The largest database of trusted experimental protocols

13 protocols using phospho akt ser473 4060

1

Immunoblotting for AKT and COX-IV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from tissues by homogenizing in RIPA buffer containing protease inhibitors. Antibodies recognizing total AKT(4691S; 1:1000; 10% acrylamide gels), phospho-AKT (Ser473; 4060S; 1:1000, 10% acrylamide gels), and cytochrome oxidase (COX)-IV (4844S; 1:1000, 15% acrylamide gels) were purchased from Cell Signaling, and actin (A-4700; 1/1000) from Sigma-Aldrich. Secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. Following detection of phospho-AKT, the membranes were stripped and re-probed with antibodies to total AKT or actin.
+ Open protocol
+ Expand
2

Western Blot Analysis of Protein Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfected PTC cells were lysed in RIPA buffer (Solarbio, China), and phenylmethylsulfonyl chloride was used as a protease inhibitor to stabilize the whole lysate. The extracted proteins were quantified by the bicinchoninic acid assay (Thermo Scientific, United States). Then the proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (BioRad, United States) followed by transferring them to the polyvinylidene difluoride (PVDF) membranes (Millipore, United States). The primary antibodies were as follows: MVP (16478-1-AP, Proteintech), phospho-AKTSer473 (4060S, Cell Signaling Technology), total-AKT (4691S, Cell Signaling Technology), phospho-mTOR (381557, Zen Bioscience), total-mTOR (380411, Zen Bioscience), Phospho-p44/42 (4370T, Cell Signaling Technology), total-p44/42 (4695T, Cell Signaling Technology), phospho-p38 (4511T, Cell Signaling Technology), total-p38 (8690T, Cell Signaling Technology), and -Actin (AP0060, Bioworld Technology). Primary antibodies were used for immunoblotting at 1:1,000 dilution. The membranes were then incubated with a secondary antibody (ab97047 or ab6728, Abcam). Eventually, proteins were detected by the chemiluminescence kit (Thermo Scientific), and images of the protein bands were quantified by ImageJ software (NIH, United States).
+ Open protocol
+ Expand
3

Antibody Immunoblotting for Insulin Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
An antibody against IRS1 (sc‐8038, 1 : 1000) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against phospho‐IRS1 (Ser612; 3193S, 1 : 1000), phospho‐AKT (Ser473; 4060S, 1 : 1000), AKT (4685S, 1 : 1000), β‐actin (4970S, 1 : 1000), GAPDH (5174S, 1 : 1000), and PPAR‐γ (2435S, 1 : 1000) were purchased from Cell Signaling Technology (Danvers, MA, USA). GPR50 (19762‐1‐AP, 1 : 1000) antibody was purchased from Proteintech (Rosemont, IL, USA).
+ Open protocol
+ Expand
4

Validation of Antibody Specificity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PKN1 antibody (ab195264) was purchased from Abcam (Cambridge, UK). FAK (#3285), phospho-FAK (Tyr397, #8556), Akt (#4685) and phospho-Akt (Ser473, #4060) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). The beta-actin antibody (60008-1-lg) was purchased from Proteintech (Wuhan, China). All antibodies were validated by the company using western blots of human cell lines. The working dilution for each antibody is listed in Supplementary Table 8. The western blot experiments were repeated independently for three times with similar results. The original full western blot plots are shown in Supplementary Fig. 9.
+ Open protocol
+ Expand
5

Investigating ACTL6A and FSHR in AKT Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
ACTL6A (ab131272) and FSH receptor (FSHR) (ab75200) antibodies were from Abcam (Cambridge, MA, USA). ACTL6A (sc-137062) mouse monoclonal antibody was from Santa Cruz (Dallas, TX, USA). AKT (#9272) and Phospho-AKT (Ser473) (#4060) antibodies were from Cell Signaling Technology (Danvers, MA, USA). PGK1 (17811-1-AP), GAPDH (10494-1-AP), and secondary antibodies were from Proteintech (Wuhan, China). FSH (869001) was from Merck (Darmstadt, Germany). LY294002 (S1105) and MK2206 (S1078) were from Selleck (Houston, USA). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) kit (C0009) was obtained from Beyotime Biotech, Inc. (Shanghai, China). Transwell® Polycarbonate Membrane (#3422) was obtained from Corning (NY, USA).
+ Open protocol
+ Expand
6

Western Blotting Optimization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blots were performed using the following antibody dilutions and standard chemiluminescent detection methods or Li-COR Bioscience Odyssey fluorescent western blotting reagents: 1:1,000 ARID1A (A301-041A, Bethyl Labs,), 1:500 IL-6 (ab6672, Abcam), 1:1000 Phospho-AKT Ser473 (4060, Cell Signaling), 1:1000 AKT (4691, Cell Signaling), 1:100 STAT3 (sc-482, Santa Cruz Biotechnology), 1:1000 Phospho-STAT3 Tyr705 (9145, Cell Signaling), and 1:5,000 βACTIN (Abcam). Membranes were blocked in 1X PBS supplemented with 5% (w/v) non-fat dry milk (Blotto A) or 1X Tris-buffered saline (TBS) [pH 7.6] supplemented with 5% (w/v) bovine serum albumin (BSA). Primary antibody incubations were performed in 1X PBS supplemented with 1% (w/v) non-fat dry milk, 1% (w/v) BSA, and 0.05% (v/v) Tween-20 (Blotto B) or 1X TBS [pH 7.6] supplemented with 5% (w/v) BSA. Western blot images have been cropped for presentation. Full size western blot images with antibody dilutions and blocking buffer conditions are presented in Supplementary Figures 9 and 10.
+ Open protocol
+ Expand
7

Characterization of anti-pUL32 Monoclonal Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-pUL32/pp150 monoclonal antibody was generated by immunization of mice with the XP1 antigen expressed in E. coli as previously described (Hensel et al., 1995 (link)). The beta-tubulin HRP antibody (ab21058) was obtained from Abcam (Cambridge, UK), the Phospho-S6 Ribosomal Protein (Ser235/236) (#2211), the Phospho-Akt (Ser473) (#4060) and the Retinoblastoma (Rb) (4H1, #9309) antibody were obtained from Cell Signaling Technology (Danvers, MA, USA). Secondary antibodies were from Jackson Immuno Research (West Grove, PA, USA). Two human immune sera of healthy donors and two commercially available intravenous immunoglobulin preparations (IVIG) (Baxter, Vienna, Austria and CSL Behring, Vienna, Austria) were applied for analysis of immunological impact after enzymatic dephosphorylation. For analysis of reactivity of immune sera with hyperphosphorylated and native pUL32, 28 different immune sera of healthy donors were used.
+ Open protocol
+ Expand
8

Western Blotting of Phosphorylated Akt

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty micrograms of protein from each extract was loaded onto 8% to 12% SDS-polyacrylamide gel electrophoresis gels and transferred to PVDF membranes (iBlot, 2PVDF Regular Stacks, Invitrogen, Thermo Fisher Scientific, Inc.) Membranes were blocked in 5% w/v bovine serum albumin (BSA), 1X TBS and 0.1% Tween® 20 at room temperature for 1 h. The membrane was incubated with diluted primary antibody (phospho-Akt [Ser473] #4060, phospho-Akt [Thr308] [D25E6] #13038, or Akt #9272 HA-Tag [C29F4] #3724; 1:1000; Cell Signaling Technology) in TBS/Tween 20 (0.1% v/v) containing 5% BSA at 4 °C overnight. After washing, the membranes were incubated with a secondary antibody (anti-mouse IgG or anti-rabbit IgG; 1:2000; Thermo Fisher Scientific, Inc.) conjugated with horseradish peroxidase, followed by detection with enhanced chemiluminescence reagents (Bio-RAD Laboratories, Inc.).
+ Open protocol
+ Expand
9

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples or cells were lysed in ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris–HCl, pH 8.0, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with a complete proteinase inhibitor (Roche Applied Sciences, Indianapolis, IN) and phosphatase inhibitor cocktails (Sigma-Aldrich, St. Louis, MO). Equal amounts of protein were resolved by SDS-PAGE and transferred to a PVDF membrane (BioRad, Hercules, CA) and blocked with anti-TGF-β1, ILK (Santa Cruz Biotechnology, Santa Cruz, CA), α-SMA (Sigma-Aldrich, St. Louis, MO), phospho-MAPK p44/42 (Thr202/Tyr204, #9101), total MAPK p44/42 (#9102), phospho-Akt (Ser473, #4060), and total Akt (#9272, Cell Signaling Technologies, Danvers, MA), followed by HRP–conjugated anti-rabbit or -mouse secondary antibodies (#7074 or #7076, Cell Signaling Technology, Danvers, MA). The blots were developed using an ECL system (PerkinElmer, Boston, MA). GAPDH (#2118, Cell Signaling Technology, Danvers, MA) was used as the loading control. The films were scanned and quantitative analysis of the ratio of phosphorylated to total MAPK p44/42, Akt or TGF-β1, ILK, and α-SMA from three independent experiments using Kodak 1D 3.5 software (Rochester, NY).
+ Open protocol
+ Expand
10

Astragaloside IV Modulates Immune Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astragaloside IV (purity > 98%) was purchased from Ronghe Co. (Shanghai, China). OVA (purity > 98%, Grade V) and methacholine (purity > 98%) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Imject alum adjuvant was obtained from Thermo Fisher Scientific Co. (Waltham, MA, USA). Dexamethasone sodium phosphate injection (purity > 99%; 5 mg/mL) was provided by Tianjin pharmaceutical group Xinzheng Co. (Tianjin, China). Rapamycin (purity > 98%) was purchased from LC Laboratories (Woburn, MA, USA). ELISA kits for INF-γ, IL-4, IL-5, IL-13, and IL-17A, FITC-labeled anti-rat CD4, APC-labeled anti-rat CD25, and PE-labeled anti-rat Foxp3 were purchased from eBioscience Co. (San Diego, USA). Antibodies for phospho-S6 ribosomal protein (Ser235/236) #4858, phospho-Akt (Ser473) #4060, Akt (#4691), phospho-4E-BP1 (Ser65) #9451, phospho-p70 S6 Kinase (Thr389) #9234, and β-actin were obtained from Cell Signaling (Danvers, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!